We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+12.64%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$3.53B
AUM Growth
+$108M
(+3.1%)
Cap. Flow
-$73.8M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
98
New
16
Increased
28
Reduced
21
Closed
18
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$51.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$50.1M |
| 3 |
FOLD
Amicus Therapeutics
FOLD
|
+$40.3M |
| 4 |
Centene
CNC
|
+$37.3M |
| 5 |
Stoke Therapeutics
STOK
|
+$27.4M |
Top Sells
| 1 |
InflaRx
IFRX
|
+$82.5M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$62.3M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$49.3M |
| 4 |
Penumbra
PEN
|
+$47.5M |
| 5 |
Xencor
XNCR
|
+$46.8M |
Sector Composition
| 1 | Healthcare | 95.47% |
| 2 | Financials | 2.17% |
| 3 | Energy | 0.01% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $405M | 11.5% |
8,752,254
-2,218,264
| -20% | -$62.3M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $284M | 8.07% |
22,792,634
+3,176,572
| +16% | +$40.3M |
|
3
Fate Therapeutics
FATE
$336M
| $210M | 5.97% |
10,359,666
| – | – |
|
4
argenx
ARGX
$54.1B
| $151M | 4.29% |
1,068,832
+49,771
| +5% | +$6.32M |
|
5
uniQure
QURE
$2.78B
| $130M | 3.7% |
1,669,525
+362,003
| +28% | +$23.1M |
|
|
BOLD
6
DELISTED
Audentes Therapeutics, Inc
BOLD
| $113M | 3.19% |
2,972,167
+236,900
| +9% | +$9.1M |
|
|
EPZM
7
DELISTED
Epizyme, Inc
EPZM
| $110M | 3.11% |
8,729,142
+1,035,122
| +13% | +$13.3M |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $99.7M | 2.83% |
2,300,301
+465,891
| +25% | +$19.1M |
|
|
ALDR
9
DELISTED
Alder Biopharmaceuticals
ALDR
| $97M | 2.75% |
8,244,896
| – | – |
|
10
Atara Biotherapeutics
ATRA
$76.3M
| $92.5M | 2.62% |
184,037
+4,620
| +3% | +$3.26M |
|
|
TCDA
11
DELISTED
Tricida, Inc. Common Stock
TCDA
| $76.8M | 2.18% |
1,945,200
+1,454,900
| +297% | +$51.2M |
|
12
eHealth
EHTH
$48.9M
| $76.5M | 2.17% |
888,705
-333,700
| -27% | -$22.5M |
|
13
Bristol-Myers Squibb
BMY
$119B
| $75.7M | 2.15% |
1,669,400
+69,700
| +4% | +$3.25M |
|
14
Tandem Diabetes Care
TNDM
$1.07B
| $75.2M | 2.13% |
1,166,032
+310,100
| +36% | +$20M |
|
15
Regenxbio
RGNX
$622M
| $71.5M | 2.03% |
1,391,376
-28,966
| -2% | -$1.45M |
|
16
Wave Life Sciences
WVE
$1.14B
| $71M | 2.01% |
2,719,707
-111,800
| -4% | -$3.14M |
|
|
WMGI
17
DELISTED
Wright Medical Group Inc
WMGI
| $70.7M | 2.01% |
2,372,157
-501,943
| -17% | -$15.3M |
|
|
18
Xencor
XNCR
$1.1B
| $66M | 1.87% |
1,612,798
-1,423,805
| -47% | -$46.8M |
|
|
19
Sarepta Therapeutics
SRPT
$1.81B
| $62.6M | 1.78% |
+412,000
| New | +$50.1M |
|
20
Elevance Health
ELV
$84.6B
| $51.8M | 1.47% |
183,500
+6,800
| +4% | +$1.86M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $51.5M | 1.46% |
557,000
+21,300
| +4% | +$2.02M |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| $51.5M | 1.46% |
3,462,300
-1,101,629
| -24% | -$19.9M |
|
|
DCPH
23
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $50.1M | 1.42% |
2,223,376
+594,723
| +37% | +$13.9M |
|
24
Scholar Rock
SRRK
$6.46B
| $46.3M | 1.31% |
2,920,389
+869,300
| +42% | +$16.1M |
|
25
Krystal Biotech
KRYS
$10.2B
| $43.5M | 1.23% |
1,080,300
+755,800
| +233% | +$24.7M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO